Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001037389-26-000005·CORCEPT THERAPEUTICS INC
Schedule 13G ownership disclosure
Corcept Therapeutics Inc
Common Stock, $0.001 par value · CUSIP: 218352102
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Renaissance Technologies LLC
Shares: 5,758,528 · Class: 5.47%
- Renaissance Technologies Holdings Corporation
Shares: 5,758,528 · Class: 5.47%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001037389-26-000005
- Form type
- SCHEDULE 13G/A
- Filer
- CORCEPT THERAPEUTICS INC
- CIK
- CIK 1088856
- Filed
- Feb 12, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership